These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34043393)

  • 1. Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance.
    Chang M; Brainerd CJ
    Neuropsychology; 2021 May; 35(4):434-450. PubMed ID: 34043393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmatory factor analysis of the ADNI Neuropsychological Battery.
    Park LQ; Gross AL; McLaren DG; Pa J; Johnson JK; Mitchell M; Manly JJ;
    Brain Imaging Behav; 2012 Dec; 6(4):528-39. PubMed ID: 22777078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.
    Dowling NM; Hermann B; La Rue A; Sager MA
    Neuropsychology; 2010 Nov; 24(6):742-756. PubMed ID: 21038965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent Factor Structure and Measurement Invariance of the NIH Toolbox Cognition Battery in an Alzheimer's Disease Research Sample.
    Ma Y; Carlsson CM; Wahoske ML; Blazel HM; Chappell RJ; Johnson SC; Asthana S; Gleason CE
    J Int Neuropsychol Soc; 2021 May; 27(5):412-425. PubMed ID: 33012297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement invariance of neuropsychological tests across different sociodemographic backgrounds in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Bertola L; Benseñor IM; Barreto SM; Moreno AB; Griep RH; Viana MC; Lotufo PA; Suemoto CK
    Neuropsychology; 2020 Feb; 34(2):227-234. PubMed ID: 31829661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement precision across cognitive domains in the Alzheimer's Disease Neuroimaging Initiative (ADNI) data set.
    Crane PK; Choi SE; Lee M; Scollard P; Sanders RE; Klinedinst B; Nakano C; Trittschuh EH; Mez J; Saykin AJ; Gibbons LE; Wang C; Mungas D; Zhu R; Foldi NS; Lamar M; Jutten R; Sikkes SAM; Grandoit E; Rabin LA; Jones RN; Tommet D; Mukherjee S
    Neuropsychology; 2023 May; 37(4):373-382. PubMed ID: 37276134
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement invariance testing of longitudinal neuropsychiatric test scores distinguishes pathological from normative cognitive decline and highlights its potential in early detection research.
    Haberstumpf S; Forster A; Leinweber J; Rauskolb S; Hewig J; Sendtner M; Lauer M; Polak T; Deckert J; Herrmann MJ
    J Neuropsychol; 2022 Jun; 16(2):324-352. PubMed ID: 34904368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal change in neuropsychological performance using latent growth models: a study of mild cognitive impairment.
    Johnson JK; Gross AL; Pa J; McLaren DG; Park LQ; Manly JJ;
    Brain Imaging Behav; 2012 Dec; 6(4):540-50. PubMed ID: 22562439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
    van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
    Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the structure of a neuropsychological battery across healthy elders and those with questionable dementia and Alzheimer's disease.
    Siedlecki KL; Honig LS; Stern Y
    Neuropsychology; 2008 May; 22(3):400-11. PubMed ID: 18444718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.
    Alegret M; Espinosa A; Ortega G; Pérez-Cordón A; Sanabria Á; Hernández I; Marquié M; Rosende-Roca M; Mauleón A; Abdelnour C; Vargas L; de Antonio EE; López-Cuevas R; Tartari JP; Alarcón-Martín E; Tárraga L; Ruiz A; Boada M; Valero S
    J Alzheimers Dis; 2021; 81(4):1541-1553. PubMed ID: 33935075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.
    Nho K; Risacher SL; Crane PK; DeCarli C; Glymour MM; Habeck C; Kim S; Lee GJ; Mormino E; Mukherjee S; Shen L; West JD; Saykin AJ;
    Brain Imaging Behav; 2012 Dec; 6(4):551-67. PubMed ID: 23070747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.
    Hayden KM; Jones RN; Zimmer C; Plassman BL; Browndyke JN; Pieper C; Warren LH; Welsh-Bohmer KA
    Alzheimer Dis Assoc Disord; 2011; 25(2):128-37. PubMed ID: 21606904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement invariance of neuropsychological measures of cognitive aging across race/ethnicity by sex/gender groups.
    Avila JF; Rentería MA; Witkiewitz K; Verney SP; Vonk JMJ; Manly JJ
    Neuropsychology; 2020 Jan; 34(1):3-14. PubMed ID: 31464473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild to moderate decrease in eGFR and cognitive decline in older adults.
    Grasing M; Kennedy K; Sarnak MJ; Burns JM; Gupta A
    Nephrol Dial Transplant; 2022 Jul; 37(8):1499-1506. PubMed ID: 34289074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement and structural invariance of a neuropsychological battery among Middle Eastern/North African, Black, and White older adults.
    Zahodne LB; Brauer S; Tarraf W; Morris EP; Antonucci TC; Ajrouch KJ
    Neuropsychology; 2023 Nov; 37(8):975-984. PubMed ID: 36996172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.
    Hayden KM; Kuchibhatla M; Romero HR; Plassman BL; Burke JR; Browndyke JN; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1364-74. PubMed ID: 24080384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor neuropsychological deficits in patients with subjective cognitive decline.
    Wolfsgruber S; Kleineidam L; Guski J; Polcher A; Frommann I; Roeske S; Spruth EJ; Franke C; Priller J; Kilimann I; Teipel S; Buerger K; Janowitz D; Laske C; Buchmann M; Peters O; Menne F; Fuentes Casan M; Wiltfang J; Bartels C; Düzel E; Metzger C; Glanz W; Thelen M; Spottke A; Ramirez A; Kofler B; Fließbach K; Schneider A; Heneka MT; Brosseron F; Meiberth D; Jessen F; Wagner M;
    Neurology; 2020 Sep; 95(9):e1134-e1143. PubMed ID: 32636322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.